Hyperactivated B cells in human inflammatory bowel disease

Journal of Leukocyte Biology

Volumn 86, Issue 4, 2009, Pages 1007-1016

  Noronha, Ansu Mammen ^a   Liang, Yanmei ^a   Hetzel, Jeremy T ^a   Hasturk, Hatice ^b   Kantarci, Alpdogan ^b   Stucchi, Arthur ^a   Zhang, Yue ^a   Nikolajczyk, Barbara S ^a   Farraye, Francis A ^a   Ganley Leal, Lisa M ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY   (United States)

Author keywords

Crohn's disease; IL 8; Inflammation; Toll like receptor 2; Ulcerative colitis

Indexed keywords

INTERLEUKIN 8; TOLL LIKE RECEPTOR 2;

ADULT; AGED; ARTICLE; B LYMPHOCYTE ACTIVATION; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE ACTIVITY; ENTERITIS; EX VIVO STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOGENESIS; MALE; MEDIATOR RELEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; ULCERATIVE COLITIS;

ADULT; AGED; B-LYMPHOCYTES; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-8; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; T-LYMPHOCYTES; TOLL-LIKE RECEPTOR 2;

EID: 70349640926     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0309203     Document Type: Article

References (59)

1. Loftus Jr., E. V. (2004) Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 126, 1504-1517.
2. Baumgart, D. C., Carding, S. R. (2007) Inflammatory bowel disease: cause and immunobiology. Lancet 369, 1627-1640. (Pubitemid 46722636)
3. Yamamoto-Furusho, J. K., Podolsky, D. K. (2007) Innate immunity in inflammatory bowel disease. World J. Gastroenterol. 13, 5577-5580. (Pubitemid 350031477)
4. Rakoff-Nahoum, S., Medzhitov, R. (2008) Role of Toll-like receptors in tissue repair and tumorigenesis. Biochemistry (Mosc.) 73, 555-561. (Pubitemid 351775078)
5. Cario, E., Gerken, G., Podolsky, D. K. (2007) Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function. Gastroenterology 132, 1359-1374. (Pubitemid 46627595)
6. Cario, E., Podolsky, D. K. (2000) Differential alteration in intestinal epithelial cell expression of Toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect. Immun. 68, 7010-7017. (Pubitemid 32463415)
7. Ganley-Leal, L. M., Liu, X., Wetzler, L. M. (2006) Toll-like receptor 2-mediated human B cell differentiation. Clin. Immunol. 120, 272-284. (Pubitemid 44175898)
8. Mansson, A., Adner, M., Hockerfelt, U., Cardell, L. O. (2006) A distinct Tolllike receptor repertoire in human tonsillar B cells, directly activated by PamCSK, R-837 and CpG-2006 stimulation. Immunology 118, 539-548. (Pubitemid 44079572)
9. Brandtzaeg, P. (2007) Induction of secretory immunity and memory at mucosal surfaces. Vaccine 25, 5467-5484.
10. Brandtzaeg, P., Carlsen, H. S., Halstensen, T. S. (2006) The B-cell system in inflammatory bowel disease. Adv. Exp. Med. Biol. 579, 149-167.
11. Braat, H., Peppelenbosch, M. P., Hommes, D. W. (2006) Immunology of Crohn's disease. Ann. N. Y. Acad. Sci. 1072, 135-154.
12. Goetz, M., Atreya, R., Ghalibafian, M., Galle, P. R., Neurath, M. F. (2007) Exacerbation of ulcerative colitis after rituximab salvage therapy. Inflamm. Bowel Dis. 13, 1365-1368. (Pubitemid 350206846)
13. Takahasi, F., Shah, H. S., Wise, L. S., Das, K. M. (1990) Circulating antibodies against human colonic extract enriched with a 40 kDa protein in patients with ulcerative colitis. Gut 31, 1016-1020. (Pubitemid 20295937)
14. Olson, T. S., Bamias, G., Naganuma, M., Rivera-Nieves, J., Burcin, T. L., Ross, W., Morris, M. A., Pizarro, T. T., Ernst, P. B., Cominelli, F., Ley, K. (2004) Expanded B cell population blocks regulatory T cells and exacerbates ileitis in a murine model of Crohn disease. J. Clin. Invest. 114, 389-398. (Pubitemid 39071611)
15. Reinisch, W., Gasche, C., Tillinger, W., Wyatt, J., Lichtenberger, C., Willheim, M., Dejaco, C., Waldhor, T., Bakos, S., Vogelsang, H., Gangl, A., Lochs, H. (1999) Clinical relevance of serum interleukin-6 in Crohn's disease: single point measurements, therapy monitoring, and prediction of clinical relapse. Am. J. Gastroenterol. 94, 2156-2164. (Pubitemid 29374547)
16. Solem, C. A., Loftus Jr., E. V., Tremaine, W. J., Harmsen, W. S., Zinsmeister, A. R., Sandborn, W. J. (2005) Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease. Inflamm. Bowel Dis. 11, 707-712. (Pubitemid 41271173)
17. Pastor Rojo, O., Lopez San Roman, A., Albeniz Arbizu, E., de la Hera Martinez, A., Ripoll Sevillano, E., Albillos Martinez, A. (2007) Serum lipopolysaccharide-binding protein in endotoxemic patients with inflammatory bowel disease. Inflamm. Bowel Dis. 13, 269-277.
18. Best, W. R., Becktel, J. M., Singleton, J. W., Kern Jr., F. (1976) Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 70, 439-444.
19. Irvine, E. J. (1999) Development and subsequent refinement of the inflammatory bowel disease questionnaire: a quality-of-life instrument for adult patients with inflammatory bowel disease. J. Pediatr. Gastroenterol. Nutr. 28, S23-S27.
20. Irvine, E. J., Feagan, B., Rochon, J., Archambault, A., Fedorak, R. N., Groll, A., Kinnear, D., Saibil, F., McDonald, J. W. (1994) Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Canadian Crohn's Relapse Prevention Trial Study Group. Gastroenterology 106, 287-296.
21. Irish, J. M., Czerwinski, D. K., Nolan, G. P., Levy, R. (2006) Kinetics of B cell receptor signaling in human B cell subsets mapped by phosphospecific flow cytometry. J. Immunol. 177, 1581-1589.
22. Liang, M. D., Zhang, Y., McDevit, D., Marecki, S., Nikolajczyk, B. S. (2006) The interleukin-1β gene is transcribed from a poised promoter architecture in monocytes. J. Biol. Chem. 281, 9227-9237. (Pubitemid 43864638)
23. Velazquez, P., Wei, B., Braun, J. (2005) Surveillance B lymphocytes and mucosal immunoregulation. Springer Semin. Immunopathol. 26, 453-462.
24. Duddy, M. E., Alter, A., Bar-Or, A. (2004) Distinct profiles of human B cell effector cytokines: a role in immune regulation? J. Immunol. 172, 3422-3427. (Pubitemid 38337921)
25. Marks, D. J., Harbord, M. W., MacAllister, R., Rahman, F. Z., Young, J., Al- Lazikani, B., Lees, W., Novelli, M., Bloom, S., Segal, A. W. (2006) Defective acute inflammation in Crohn's disease: a clinical investigation. Lancet 367, 668-678. (Pubitemid 43289157)
26. Stallmach, A., Giese, T., Schmidt, C., Ludwig, B., Mueller-Molaian, I., Meuer, S. C. (2004) Cytokine/chemokine transcript profiles reflect mucosal inflammation in Crohn's disease. Int. J. Colorectal Dis. 19, 308-315. (Pubitemid 38868295)
27. Konrad, A., Lehrke, M., Schachinger, V., Seibold, F., Stark, R., Ochsenkuhn, T., Parhofer, K. G., Goke, B., Broedl, U. C. (2007) Resistin is an inflammatory marker of inflammatory bowel disease in humans. Eur. J. Gastroenterol. Hepatol. 19, 1070-1074. (Pubitemid 350125378)
28. Sims-Mourtada, J. C., Guzman-Rojas, L., Rangel, R., Nghiem, D. X., Ullrich, S. E., Guret, C., Cain, K., Martinez-Valdez, H. (2003) In vivo expression of interleukin-8, and regulated on activation, normal, T-cell expressed, and secreted, by human germinal centre B lymphocytes. Immunology 110, 296-303. (Pubitemid 37378495)
29. Bohnhorst, J. O., Bjorgan, M. B., Thoen, J. E., Natvig, J. B., Thompson, K. M. (2001) Bm1-Bm2 classification of peripheral blood B cells reveals circulating germinal center founder B cells in healthy individuals and disturbance in the B cell populations in patients with primary Sjogren's syndrome. J. Immunol. 167, 3610-3618.
30. Aaronson, D. S., Horvath, C. M. (2002) A road map for those who don't know JAK-STAT. Science 296, 1653-1655.
31. Bossen, C., Schneider, P. (2006) BAFF, APRIL and their receptors: structure, function and signaling. Semin. Immunol. 18, 263-275. (Pubitemid 44287558)
32. MacLeod, H., Bhasin, N., Wetzler, L. M. (2008) Role of protein tyrosine kinase and Erk1/2 activities in the Toll-like receptor 2-induced cellular activation of murine B cells by neisserial porin. Clin. Vaccine Immunol. 15, 630-637. (Pubitemid 351967045)
33. Taneichi, H., Kanegane, H., Sira, M. M., Futatani, T., Agematsu, K., Sako, M., Kaneko, H., Kondo, N., Kaisho, T., Miyawaki, T. (2008) Toll-like receptor signaling is impaired in dendritic cells from patients with X-linked aγglobulinemia. Clin. Immunol. 126, 148-154.
34. Frolova, L., Drastich, P., Rossmann, P., Klimesova, K., Tlaskalova- Hogenova, H. (2008) Expression of Toll-like receptor 2 (TLR2), TLR4, and CD14 in biopsy samples of patients with inflammatory bowel diseases: upregulated expression of TLR2 in terminal ileum of patients with ulcerative colitis. J. Histochem. Cytochem. 56, 267-274.
35. Szebeni, B., Veres, G., Dezsofi, A., Rusai, K., Vannay, A., Mraz, M., Majorova, E., Arato, A. (2008) Increased expression of Toll-like receptor (TLR) 2 and TLR4 in the colonic mucosa of children with inflammatory bowel disease. Clin. Exp. Immunol. 151, 34-41. (Pubitemid 350230984)
36. Hausmann, M., Kiessling, S., Mestermann, S., Webb, G., Spottl, T., Andus, T., Scholmerich, J., Herfarth, H., Ray, K., Falk, W., Rogler, G. (2002) Toll-like receptors 2 and 4 are up-regulated during intestinal inflammation. Gastroenterology 122, 1987-2000. (Pubitemid 34651441)
37. De Jager, P. L., Franchimont, D., Waliszewska, A., Bitton, A., Cohen, A., Langelier, D., Belaiche, J., Vermeire, S., Farwell, L., Goris, A., Libioulle, C., Jani, N., Dassopoulos, T., Bromfield, G. P., Dubois, B., Cho, J. H., Brant, S. R., Duerr, R. H., Yang, H., Rotter, J. I., Silverberg, M. S., Steinhart, A. H., Daly, M. J., Podolsky, D. K., Louis, E., Hafler, D. A., Rioux, J. D. (2007) The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases. Genes Immun. 8, 387-397. (Pubitemid 47163102)
38. Ganley-Leal, L. M., Mwinzi, P. N., Cetre-Sossah, C. B., Andove, J., Hightower, A. W., Karanja, D. M., Colley, D. G., Secor, W. E. (2006) Correlation between eosinophils and protection against reinfection with Schistosoma mansoni and the effect of human immunodeficiency virus type 1 coinfection in humans. Infect. Immun. 74, 2169-2176.
39. Haehnel, V., Schwarzfischer, L., Fenton, M. J., Rehli, M. (2002) Transcriptional regulation of the human Toll-like receptor 2 gene in monocytes and macrophages. J. Immunol. 168, 5629-5637. (Pubitemid 34556144)
40. Wang, T., Lafuse, W. P., Zwilling, B. S. (2001) NFκB and Sp1 elements are necessary for maximal transcription of Toll-like receptor 2 induced by Mycobacterium avium. J. Immunol. 167, 6924-6932. (Pubitemid 33144186)
41. Scapini, P., Lapinet-Vera, J. A., Gasperini, S., Calzetti, F., Bazzoni, F., Cassatella, M. A. (2000) The neutrophil as a cellular source of chemokines. Immunol. Rev. 177, 195-203.
42. Van Kruiningen, H. J., Ganley, L. M., Freda, B. J. (1997) The role of Peyer's patches in the age-related incidence of Crohn's disease. J. Clin. Gastroenterol. 25, 470-475.
43. Veidenheimer, M. C. (1972) Clinical differentiation between Crohn's disease of the colon and chronic ulcerative colitis. Proc. R. Soc. Med. 65, 972-973.
44. Gutierrez, A., Frances, R., Amoros, A., Zapater, P., Garmendia, M., Ndongo, M., Cano, R., Jover, R., Such, J., Perez-Mateo, M. (2009) Cytokine association with bacterial DNA in serum of patients with inflammatory bowel disease. Inflamm. Bowel Dis. 15, 508-514.
45. Muratov, V., Ulfgren, A. K., Engstrom, M., Elvin, K., Winqvist, O., Lofberg, R., Lundahl, J. (2008) Decreased numbers of FoxP3-positive and TLR-2-positive cells in intestinal mucosa are associated with improvement in patients with active inflammatory bowel disease following selective leukocyte apheresis. J. Gastroenterol. 43, 277-282. (Pubitemid 351650038)
46. Banks, C., Bateman, A., Payne, R., Johnson, P., Sheron, N. (2003) Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease. J. Pathol. 199, 28-35. (Pubitemid 36054726)
47. Nielsen, O. H., Rudiger, N., Gaustadnes, M., Horn, T. (1997) Intestinal interleukin- 8 concentration and gene expression in inflammatory bowel disease. Scand. J. Gastroenterol. 32, 1028-1034. (Pubitemid 27433666)
48. Foell, D., Kucharzik, T., Kraft, M., Vogl, T., Sorg, C., Domschke, W., Roth, J. (2003) Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease. Gut 52, 847-853. (Pubitemid 36613492)
49. Damen, G. M., Hol, J., de Ruiter, L., Bouquet, J., Sinaasappel, M., van der Woude, J., Laman, J. D., Hop, W. C., Buller, H. A., Escher, J. C., Nieuwenhuis, E. E. (2006) Chemokine production by buccal epithelium as a distinctive feature of pediatric Crohn disease. J. Pediatr. Gastroenterol. Nutr. 42, 142-149.
50. Hechtman, D. H., Cybulsky, M. I., Fuchs, H. J., Baker, J. B., Gimbrone Jr., M. A. (1991) Intravascular IL-8. Inhibitor of polymorphonuclear leukocyte accumulation at sites of acute inflammation. J. Immunol. 147, 883-892.
51. Zwahlen, R., Walz, A., Rot, A. (1993) In vitro and in vivo activity and pathophysiology of human interleukin-8 and related peptides. Int. Rev. Exp. Pathol. 34 (Pt B), 27-42.
52. Brandtzaeg, P., Johansen, F. E. (2005) Mucosal B cells: phenotypic characteristics, transcriptional regulation, and homing properties. Immunol. Rev. 206, 32-63. (Pubitemid 41105162)
53. Pabst, R., Russell, M. W., Brandtzaeg, P. (2008) Tissue distribution of lymphocytes and plasma cells and the role of the gut. Trends Immunol. 29, 206-208.
54. Bekeredjian-Ding, I., Inamura, S., Giese, T., Moll, H., Endres, S., Sing, A., Zahringer, U., Hartmann, G. (2007) Staphylococcus aureus protein A triggers T cell-independent B cell proliferation by sensitizing B cells for TLR2 ligands. J. Immunol. 178, 2803-2812. (Pubitemid 46333158)
55. Lindvall, J. M., Blomberg, K. E., Valiaho, J., Vargas, L., Heinonen, J. E., Berglof, A., Mohamed, A. J., Nore, B. F., Vihinen, M., Smith, C. I. (2005) Bruton's tyrosine kinase: cell biology, sequence conservation, mutation spectrum, siRNA modifications, and expression profiling. Immunol. Rev. 203, 200-215. (Pubitemid 40185385)
56. Horwood, N. J., Page, T. H., McDaid, J. P., Palmer, C. D., Campbell, J., Mahon, T., Brennan, F. M., Webster, D., Foxwell, B. M. (2006) Bruton's tyrosine kinase is required for TLR2 and TLR4-induced TNF, but not IL-6, production. J. Immunol. 176, 3635-3641. (Pubitemid 43364011)
57. Shin, H., Zhang, Y., Jagannathan, M., Hasturk, H., Kantarci, A., Liu, H., Van Dyke, T. E., Ganley-Leal, L. M., Nikolajczyk, B. S. (2008) B cells from periodontal disease patients express surface Toll-like receptor 4. J. Leukoc. Biol. 85, 648-655.
58. Jang, M. H., Sougawa, N., Tanaka, T., Hirata, T., Hiroi, T., Tohya, K., Guo, Z., Umemoto, E., Ebisuno, Y., Yang, B. G., Seoh, J. Y., Lipp, M., Kiyono, H., Miyasaka, M. (2006) CCR7 is critically important for migration of dendritic cells in intestinal lamina propria to mesenteric lymph nodes. J. Immunol. 176, 803-810. (Pubitemid 43099676)
59. Medzhitov, R. (2007) Recognition of microorganisms and activation of the immune response. Nature 449, 819-826. (Pubitemid 47598622)